Agenda - Day 1

There are no agenda items with this track

9:00 am

9:00 am

NETWORKING

Enter Networking Lounge, Connect with your Industry Colleagues

  • Start your day off right and make connections with industry leadership.
  • Join “drop-in” roundtables discussing current and relevant topics.
  • Schedule 1-2-1 video meetings with peers or vendors.
  • Gather essential content and get exclusive offers at virtual exhibit booths.

10:00 am

10:00 am

Welcome from your Host

Gain insight into today’s sessions so you can get the most out of your experience and maximize your value.

10:10 am

10:10 am

Opening Keynote: CANADIAN HEALTHCARE LANDSCAPE

Position your Company to Succeed in the Brave New World of Canadian Healthcare

Canadians were severely impacted during COVID-19 due to a lack of domestic pharmaceutical R&D and manufacturing. Is now the time for a reset to the industry/government partnership? Set your company up for future success with insights from an experienced and objective voice, André Picard. Engage in a high-level conversation on:

  • The history of the pharma industry in Canada
  • Valuable lessons to actionable learnings from the pandemic
  • Indications that ‘the times, they are a changing’

 

Carve out your company’s place in the evolving world of Canadian healthcare.

11:00 am

11:00 am

Panel Discussion: VIEW FROM THE TRENCHES

Overcome Risk and Seize Opportunities with Insight from Canada’s Key Health System Players

The Canadian pharmaceutical landscape is changing at a rapid pace. This includes recent updates to PMPRB regulations, a new CADTH compliance process and emerging opportunities in rare diseases — all against the backdrop of a pandemic-shaken health system. Determine the immediate and future impact on your business through dialogue with government, regulatory, industry and patient group leaders. Take away an action plan to:

  • Uncover emerging opportunities within Canada’s impending national strategy for high-cost drugs for rare diseases.
  • Incorporate best practices and lessons learned during the COVID-19 pandemic.
  • Overcome early stumbling blocks surrounding the updated PMPRB regulations.

Prepare your organization for opportunity and risk in the ‘new normal.’

11:30 am

11:30 am

Fireside Chat: CADTH UPDATE

Navigate CADTH Amendments to Achieve a Successful Submission the First Time Around

The CADTH drug review process has new revisions based on learnings from the COVID-19 pandemic. Strengthen your company’s bottom line by accurately interpreting the impact of these changes. Source intelligence to:

  • Gain a comprehensive understanding of the information requirements for drug submissions to CADTH.
  • Adopt best practices to better manage your product submissions under the revised process.
  • Navigate the changes seamlessly and efficiently.

Position your product for a successful submission through the updated CADTH review process.

12:00 pm

12:00 pm

Industry Expert: IQVIA

12:30 pm

12:30 pm

Panel Discussion: RARE DISEASE MARKET OUTLOOK

Paving the Way Forward for Rare Disease Therapies with Lessons Learned from COVID-19

Health Canada is preparing to implement a national strategy to help fund high-cost drugs for rare diseases by 2022–2023. How can you best prepare, and what can we learn from the COVID-19 vaccine journey? Inform your market access strategy with the experience of these market leaders. Establish your game plan by:

  • Determining the types of partnerships and funding that will be key to the successful development of drugs for rare diseases
  • Analyzing the impact of recently increased government funding on the overall treatment pipeline
  • Visualizing potential safe and expeditious routes to commercialization for these medicines

Chart a course to succeed in the new market access model for rare disease therapies

1:00 pm

1:00 pm

NETWORKING

Build Relationships and Visit Virtual Booths

Expand your network and exchange expertise with your peers. Take advantage of our intuitive platform to deepen your knowledge and connect with industry leaders and experts.

  • Pose your biggest questions to leading solution providers through 1:1 video conversations or chat.
  • Join “drop-in” roundtables in the networking lounge and make connections that last beyond these two days.
  • Experience live demos and test drive new technology. Source leading-edge content from virtual booths.

1:30 pm

1:30 pm

Afternoon Keynote: INTERNATIONAL REFERENCE PRICING (IRP)

An Overview and Outlook for IRP in North America

IRP is a frequently tossed-around term used in reference to controlling rising drug prices in both Canada and the US. Leverage an in-depth understanding of the history and future consequences for your brands/products. Gain critical insights including:

  • Incorporating IRP, the absence of price transparency and role of confidential agreements & patient access schemes
  • Informing yourself via a case study how the new basket of 11 reference countries is intended to lower Canadian drug prices to OECD median
  • Evaluating the proposed US IRP regulatory proposals and their potential for implementation in current political environment

Assess the impact of IRP on your upcoming launch sequencing & patient access

2:00 pm

2:00 pm

Panel Discussion: THE ROAD TO ADVANCED THERAPEUTICS

Assessing the State of Play: Are Gene Therapies the Next Big Game Changer?

Although still considered by some as an experimental technique, gene therapy is expected to become much more prevalent. Inform your development pipeline with an in-depth understanding of new approaches to gene therapy, including:

  • Replacing a mutated disease-causing gene with a healthy copy of the gene
  • Inactivating (or “knocking out”) a mutated gene that is functioning improperly
  • Introducing a new gene into the body to help fight a disease

Equip your team with actionable insights for developing effective gene therapy products.

2:30 pm

2:30 pm

Industry Expert: REAL-WORLD EVIDENCE

Discover How Real-World Evidence is Impacting Drug Development and Approval

It is now commonly required for governments, industry players and other stakeholders to provide quality data to support their submissions for reimbursement. This was evident with the expedited approval of the COVID-19 vaccines. Improve the value proposition of your medicines with new approaches using Real-World Evidence (RWE). Source practical tips to:

  • Enhance the efficacy of your medications on individual patient outcomes.
  • Evaluate the impact of RWE on overall population health of patients taking your medication.
  • Partner with stakeholders to access data pertinent to reimbursement.

Prove and improve the value, efficacy and impact of your medications with RWE.

3:00 pm

3:00 pm

Panel Discussion: PRIVATE PAYERS’ PERSPECTIVE

Carve A Pathway to Access & Reimbursement with Private Payers

There are new and increased barriers to access in the current private payer market. This is due to continued tightening of access to private payer formularies combined with some payers moving to outsource benefit plans and administration to third parties. Hone your private payer access strategy by understanding new market developments and payer priorities. Create an action plan to:

  • Leverage elements of successful public PLA submissions and adapt them for the private payer market.
  • Analyze the influence of public payer decisions on private payers to gain a better understanding of the private market.
  • Discover what pharma companies can do to maximize the ROI of their submissions to private payers.

Gain insight into what private payers need to succeed with a tailored approach to securing a PLA.

3:30 pm

3:30 pm

Summary from your Host

Review the key solutions and takeaways from today’s sessions. Source a summary of actions points to implement in your work. Discuss tomorrow’s highlights!

3:35 pm

3:35 pm

Virtual Happy Hour

  • Get to know fellow delegates in “drop-in” virtual roundtables.
  • Engage in 1:1 video conversation with peers or vendors.
  • Connect with other attendees based on similar interests and business objectives using our “recommend matches” tool.

4:00 pm

4:00 pm

Conference Day 1 Adjourns

Get the latest news

*Privacy Policy